Following abdominal wall surgery, incisions are commonly sutured, stapled, or glued together by primary intention. Developments within the field of tissue engineering have led to the use of prosthetic meshes, with over 20 million meshes implanted each year worldwide. The function of the mesh is to hold together abdominal wall incisions and repair abdominal hernias. This has been demonstrated to be highly effective in some individuals; however, some patients have experienced postoperative complications, including dehiscence with further abdominal herniation (viscera protruding through the abdominal wall). Little is currently known about why these complications occur in a subset of patients who have had prosthetic mesh implants in abdominal wall repairs; therefore, this literature review examined existing studies identified via six electronic databases. A total of 463 studies were identified, of which 13 were included in this review. The results identified that the prosthetic mesh is highly successful in a large proportion of patients who have had a had a hernia repair in a range of locations; however, the prosthetic mesh has long-term complications, with rejection being observed in a subset of patients. The reason why the prosthetic is being rejected is still largely unknown, and therefore, further investigation needs to be carried out.
laparoscopy surgery, 13%-21% of individuals experience an incisional hernia, triggering a large number of incisional hernial repairs. 4 Hernial repairs pose a difficult reconstructive challenge for many surgeons because most are caused by a combination of high intra-abdominal pressure and weakened abdominal wall and thus have a high possibility of recurrence. 5 Prosthetic mesh as a method of repair is commonly used. 6 However, underlying factors such as malnutrition, the repair techniques, and any secondary pathology, for example, wound infection, may lead to wound dehiscence. 7 
| Principles underpinning the use of prosthetic meshes to aid abdominal wall repair
Decades of research has been carried out on the use of prosthetic mesh in abdominal wall surgery, with over 20 million prosthetic meshes implanted each year worldwide. 8 Very large incisions or complex abdominal hernias are still a perplexing problem in patients with major risks of wound infections, and this has led to the development of prosthetic meshes, which have been in use since 1891. 9 Since the first mesh was developed, there has been great advances in this field aiming to reduce the occurrence of postoperative infection, hernias, and mesh rejections. 10 The ideal prosthetic mesh should be durable, non-carcinogenic, inert, non-immunogenic, and non-biodegradable whilst the wound heals. 10 Most current prosthetic meshes encompass all these properties; however, there is a subset of patients who experience wound dehiscence, leading to controversy as to whether it is the mesh that has caused the problems or if it is a measure of the failure of the surgical procedure. 11 The underlying cause and mechanisms as to why the mesh is being rejected in certain patients are still widely unknown.
It has been estimated that there were over 2.2 million wounds managed by the NHS in 2012-2013, with the economic burden placed on the NHS for chronic wounds being comparable with that of managing obesity (estimated at a cost of £5 billion). 12 A chronic or non-healing wound has a profound effect on patients' health, lifestyle, and psychological health. 13 Dehiscence as a consequence of prosthetic mesh complications can lead to stress and anxiety, with many patients developing a psychological stress response, further influencing the repair process. 15 The purpose of this current review is to identify existing evidence on the impact of such complications in order to determine how common these were.
| METHOD
The aim of this literature review was to identify studies that have examined the use of prosthetic mesh in patients who have had an abdominal hernia repair.
| Search strategy
Studies were identified by searching the electrical databases of PubMed, Scopus, Cochrane Library, EMBASE, DARE, and HTA. The search terms used for the databases were: "prosthetic mesh," "prosthetic mesh abdominal hernias" "prosthetic mesh abdominal hernia repair," and "prosthetic mesh hernia."
| Inclusion and exclusion criteria for study selection
Evidence was selected based on the following criteria: clinical trials in humans within the last 10 years. Studies carried out on animals were excluded as the focus was on the outcomes in humans. The title and the abstract of the study was read to check if the study was relevant. Studies were excluded if they did not focus on prosthetic mesh repairs and abdominal implantation use and if they did not fit within the locations of interest ( Figure 1 illustrates the study selection process). A criterion of 10 years was used to allow the summary of recent studies.
| Data extraction
Information extracted from the studies included the authors, title, the source of the study, year of publication, and the type of publications. The characteristics of the studies were also extracted, which included study design, outcomes, results, and sample size.
| RESULTS
A summary of the studies is provided in Tables 2-6 .
| Ventral hernia
Kroese et al 4 examined the long-term complications of selfgripping mesh (ProGrip-mesh-Monofilament Polyethylene Terephthalate, Medtronic, Trevoux, France) in 46 patients. The characteristics of the sample are shown in Table 7 . Follow up was carried out after 2 months to analyse the postoperative complications or recurrences and to evaluate the pain of the patients. From the study, the authors found that the majority of patients (72%, n = 28) reported no complaints from the mesh; however, 5% (n = 2) required reoperation, 
Key Messages
• there is a consensus that repairing hernias by mesh, instead of suturing alone, is more effective
• overall, this review identified that the repair of abdominal hernias with prosthetic mesh can reduce the risk of hernia recurrence
• a limitation of the existing evidence is the short duration of follow up, which makes it difficult to determine the long-term outcomes; therefore, further studies are needed
• obesity, diabetes, and hypertension increase the risk of postoperative complications after abdominal hernia wall repair, and the evidence suggests that there also appears to be a female preponderance for mesh failure
• the development of specific patient selection criteria to optimise successful outcomes may be useful and 3% (n = 1) developed a mesh infection. 4 Limitations of the study include the small sample size, which limits the generalisability; furthermore, follow up was undertaken by telephone interview, which can be an unreliable reporting mechanism for complications, and the length of the follow up was short, 2 months. Sommer and Friis-Andersen 14 also investigated the use of prosthetic mesh in ventral hernias. They investigated the complications associated with DynaMesh (polyvinylidene fluoride) implantation (FEG Textiltechnik mbH in Aachen, Germany) in patients undergoing laparoscopic ventral hernia repair. Patients were selected between a period of 1st January 2005 and 31st December 2010 (n = 181). Postoperative complications were assessed by telephone interviews. The authors reported that 11 patients required reoperation because of complications with the mesh, 3 patients had a small bowel obstruction, and 1 had a colic fistula with mesh infection, all of which required mesh removal. An abdominal wall hernia was also seen in two patients. The median follow-up time was 34 months in 140 patients, 66% of whom reported no pain. This study showed that the use of DynaMesh in laparoscopic ventral hernia repair did have a successful outcome, with only a 6% (n = 8) rate of meshrelated complications; however, 19% (n = 27) of patients did have moderate pain at follow up. A limitation of this study was that postoperative complications were assessed by telephone interview, which can be an unreliable method to collect data and reduces the reliability of the results.
| Incisional hernia
Briennon et al 16 investigated the use of a composite mesh (Parietex composite polyester mesh, Covidien-Sofradim, Trevoux, France) in the surgical treatment of large incisional hernias (n = 280). Postoperative follow up was performed by the surgical team that implanted the mesh, and patients were monitored for a year and then annually for 5 years. The results showed that 2% (n = 6) developed an infection at the surgical site, 2% (n = 6) developed a deep-seated infection, and a further three patients had to have the mesh removed completely. These results suggest that the complication rate was low. However, postoperative complications occurred in 58 patients (20.7%); these complications may have been related to the mesh, but the author did not discuss this directly (Table 8 ).
Postoperative follow up of patients ranged from 12 months to 9 years (n = 8 were lost, n = 3 died). Hernia recurrence was found in 3.2% of patients (n = 9) occurring 6-9 months after surgery. A relatively large proportion of the sample had comorbidities such as obesity, smoking, alcoholism, thromboembolic pathology, and insulin-dependent diabetes. The duration of follow up was relatively long and thus gives us an idea of the long-term use of Parietex composite mesh. However, the follow up was performed by the surgical team that implanted the mesh, which may have biased the internal validity of the study as well as the reliability of the results. To reduce the risk of bias, an independent assessor should have performed the follow up. A more recent study that investigated the long-term complication risk associated with incisional hernia repair using prosthetic mesh (mesh types included polypropylene (PPL), coated PPL, expanded polytetrafluoroethylene (ePTFE), PPL plus ePTFE, coated polyester, or other types such as biological mesh, completely, absorbable synthetic mesh, and not specified) was undertaken by Kokotovic et al 17 From studying 3242 patients with incisional repair surgery, they found that the risk of hernia reoccurrence that required further The aim of the study was to look into the treatment of large incisional hernias by Parietex composite mesh.
Parietex composite mesh-polyester mesh
patients
The outcome of the study verified that mesh can be helpful in the wound healing in large ventral incisional hernias. The incidence of complications in the study was very low. The aim of the study was to investigate the benefits and risks of mesh reinforcement versus conventional stoma formation in preventing parastomal herniation.
Composite or biologic mesh was used 129 patients From the study, they found that composite or biological mesh reinforcement of stomas is associated with a reduced incidence of parastomal herniations, with no excess morbidity. They also found there was a reduced incidence rate of further parastomal herniation requiring surgery.
Randomised control trial (1A)
Cochrane library 2012 López-Cano et al 24 The purpose of the study was to investigate the use of prosthetic mesh to prevent a parastomal hernia in a laparoscopic abdominoperineal resection The aim of the study was to achieve a long-term follow up by repairing incisional hernias with full-thickness fixation of on lay mesh.
Polypropylene
Prolene mesh
patients
The full-thickness mesh mechanically supported the fascia and enabled homogenous fibrous healing in a wide area.
Long-term follow-up study (2C) a Level of Evidence according to the Centre for Evidence-Based Medicine. 34 operations was lower for patients with open mesh repair (12.3%, n = 138) compared with patients with no mesh repair (17.1%, n = 63). Overall, the authors found that mesh repair was associated with lower risk of reoperation for recurrence over the subsequent 5 years. However, during the 5-year follow up, a small number of patients had meshrelated complications in the open hernia repair and laparoscopic mesh repair groups (respectively 5.6% and 3.7%). Therefore, the authors questioned the long-term benefit of using a prosthetic mesh. 17 The results were promising; however, during the follow up, there was a progressive increase in the number of mesh-related complications, for example, bowel obstruction, bowel perforation, bleeding, and late abscesses. There was also no statistically significant difference in the reported pain scores (VAS score and a verbal scale) between Lichtenstein's Operation and mesh plug repair (P > 0.05). These methods were not able to determine the superiority of the use of mesh in terms of recurrence rates or pain in this sample of patients. There were also a few limitations to the study, for example, the follow-up information from the patients after 6.5 years was limited to 444 cases (75%), although this was mainly because of the death of patients, which the authors stated were not related to the hernia repair. Furthermore, patients were not blinded to the operative technique, which may have biased their responses. In addition, the study included a high proportion of older and retired patients (mean age 58 in both groups); therefore, the results may not be generalisable to a younger population. However, the pain score was assessed using the VAS score, which is a reliable method to measure pain 19 and is a standard assessment tool in many studies.
| Inguinal hernia
A study by Wang and Zhang 20 examined the short-term results of inguinal hernia repairs with a "self-gripping" mesh (Parietex ProGrip-a monofilament polyester textile on one side and a hydrophilic absorbable collagen film on the other side) in a sample of 90 patients (66 males and 24 females).
The mesh implantation took place in a single hospital in China between July 2012 and June 2013. The patients were followed up for 6 months postoperatively. During this time, none of the patients had recurrent hernias or systemic postoperative complications. The results also showed that, from the day the mesh was implanted, there were marked improvements in health and health-related quality of life (mean AE SD visual analogue scale EuroQoL score). The EuroQoL score increased from 55.3 AE 8 to 95.2 AE 3 to 0.95 AE 0.02 from day 1 to 6 months. The authors concluded that inguinal hernia repair with the Lichtenstein approach using the self-gripping mesh is a safe and effective method of repair. However, the sample size was small, and the follow up was relatively short; thus, any potential longer-term effects may have been missed, which needs to be considered when interpreting the results. All 90 patients were followed up at baseline and at 6 months, where the SF-36 (36-item short form survey) was used to determine the patientreported outcomes. The advantages of this technique are that it is simple to administer, and forms can be mailed to patients, increasing the response rate; however, it is common for a patient to miss items from the questionnaire and thus have incomplete results, and some items have been questioned for their relevance to elderly populations. 20 Gemici et al 21 investigated the recurrence rate of fullthickness mesh (Prolene a PPL prolene mesh) fixation in incisional hernia repair in a total of 154 subjects (107 females and 47 males). The mean age of patients was 52.6 years, the mean follow-up time was 54 months (SD 22.8 months), and average operation times was 128 minutes. Of the total number, 8 patients (5.2%) developed hernia recurrence after the full-thickness mesh was implanted, and 10 patients (6.5%) had chronic pain in the operative area for longer than 3 months. The authors discussed that the implanted fullthickness mesh enabled fibrous wound healing, which they suggested prevented migration of the mesh and reduced the occurrence of an incisional hernia. A strength of the study was that the same surgeon carried out all the procedures, reducing the risk of variability in the surgical technique. However, because it was observational, there was no randomisation or blinding of participants, which may have led to bias.
| Parastomal hernia
Guzman-Valdivia et al 22 examined the use of lightweight PPL mesh (name of product not disclosed) in parastomal hernia repair (n = 125). Of the total number, 40% presented with a parastomal hernia (n = 50), of which 25 underwent further surgery. The patients were followed up for an average of 12 months (range 8-24 months). Post-intervention, two patients experienced a reoccurrence of their hernias and had to undergo further surgery with a new mesh prosthetic; two patients experienced a wound infection, and two patients developed a seroma. However, the authors reported that there were no cases of mesh rejection, erosion of the colon, or fistula formation. Overall, the authors concluded that inserting a mesh prosthesis using this technique was a safe effective treatment for the repair of parastomal hernias. However, the sample of patients was small, which limits the external validity of the study. Where complications did arise, the authors stated that these were because of other comorbidities such as diabetes mellitus and chronic renal failure. This study was an observational study, the limitations of which are that there was limited control over outcomes assessed. Wijeyekoon et al 23 carried out a meta-analysis of 129 patients (from three trials) to determine the benefits and risks of mesh reinforcement (composite or biological mesh) versus conventional stoma formation in preventing parastomal herniation. The mesh types used within this study included; Tissue Science Laboratories Plc)-porcine derived acellular collagen matrix, Vipro (Ethicon, Inc.)-synthetic mesh with low content of prolene (non-absorbable) and Ultrapro (Ethicon, Inc.)-approximately equal parts of prolene (non-absorbable) and Monocryl (absorbable). The authors found that mesh reinforcement was associated with a reduced rate of a parastomal hernia versus stoma formation (P = 0.02). They also found that placement of the mesh did not have an effect on mortality, with either mesh being associated with a reduced rate of parastomal herniation. The mesh also showed a decreased incidence of parastomal herniation requiring further surgical repair. However, it is based on a small sample of patients, which limits the wider generalisability. López-Cano et al 24 assessed whether the implantation of large-pore lightweight mesh (PROCEED Surgical Mesh, Ethicon Inc., Johnson & Johnson) in patients undergoing laparoscopic abdominoperineal resection prevented a parastomal hernia. Thirty-six patients were randomised into two groups: 19 to mesh group and 17 to a control group. They were randomised by a computer-generated list of random numbers generated by an independent statistician. The presence of a parastomal hernia was identified by a CT scan performed 12 months after surgery. Parastomal herniation was detected in 93.8% (n = 16) of the control group and 50% (n = 10) of patients in the mesh group. Subcutaneous fat thickness was recorded, with >23 mm being a significant predictor of a parastomal hernia. Overall, this was a weak study because of the small sample size and because the mesh was inserted by six different surgeons. The variety of surgeons makes the study less reliable as they may have inserted the meshes in slightly different ways, which reduce the internal validity of the study.
| Midline abdominal hernia
An observational study carried out by El-Khadrawy et al 25 investigated the use of PPL mesh implantation (type of mesh no disclosed) in high-risk patients (n = 40) to determine the long-term protective use of the device. The high-risk factors included: diabetes, old age, renal impairment, malignancy, chest problems, steroid therapy, and malignancy. The sample was identified and randomly divided into two groups;
Group A included patients who were closed by the conventional method with mesh, and Group B included patients who were closed by conventional method only (20 in each group). The results showed that there were no statistically significant differences between the groups in terms of age and gender (P > 0.05). Furthermore, there was no statistically significant difference in local and systemic complication rates in the two groups (P > 0.05). However, three patients suffered from chronic wound pain with prosthetic mesh compared with none in group B. Local and systemic postoperative complications included deep vein thrombosis, surgical site infection, subcutaneous seroma, chronic wound pain, and cardiac problems. The results of this study suggest that mesh reinforcement can be used safely in high-risk patients. However, El-Khadrawy et al 25 proposed that further long-term work was needed to examine the long-term risks of prosthetic mesh to support the findings found in this study in such a small sample size. A further limitation of this study was that the two groups included patients with a different number of high-risk factors, which potentially skews the results in favour of group B as it had a lower number of risk factors in the group (Table 9 ). In addition, as this was an observational study, this poses concern about the generalisability of the results.
A more recent study by Abo-Ryia et al 26 investigated the safety and efficacy of pre-peritoneal prosthetic enforcement of midline incisions in patients undergoing bariatric surgery. In this study, 64 patients were included and randomised to either have a PPL mesh implant or closure by conventional methods. Of the total number, there were 51 females and 13 males (ratio 4:1). The results showed that there were no statistically significant differences for gender, mean age, body weight, mean hospital stay (days), and mean follow-up period (months) between the groups ((P < 0.05) (Table 10) . Patients were followed up at intervals of 1, 3, 6, and 12 months and then yearly thereafter. The follow up was carried out to detect the development of an incisional hernia where the ultra-sonographic assessment was undertaken in suspected cases. The authors concluded that the use of prolene mesh during wound closure in open bariatric surgery was safe and effective in preventing incisional hernia development. A major limitation of the study was the small number of patients, and to increase the reliability of the study, a larger sample size is needed. In addition, there needed to be more of a gender balance. It has been indicated that, in England, more women have bariatric surgery 27 ; therefore, this might explain the higher number of females in the study.
A previous retrospective observational study by Lupinacci et al 28 investigated the use of biological mesh (bioprosthetic mesh/manufacturer was not disclosed) for abdominal hernias repairs. The primary endpoint of the study was the incidence of wound events such as haematoma, dehiscence of the incision, infection of the wound, and prosthetics removal. The secondary endpoint was the duration of hospital stay, wound chronic pain, and hernia recurrence. There were 20 men and 22 women in the cohort, with an average of 61 years (range from 26-90 years). The number and rate of hernia repairs were 25 (58%) incisional, 14 (32%) parastomal, and 4 (10%) midline. Follow up was carried out at an average of 8 months (2-27 months), where pain and wound-related complications were assessed. From the 42 patients studied, 17 (40%) patients had a woundrelated morbidity, and 4 (10%) patients required re-operation for an abscess or necrosis. Smoking was identified as a major risk factor. It was also noted that wound-related events and surgical technique were not statistically related to chronic pain (P > 0.05). The results also showed that wound-related complications were frequent (39%, n = 16); for example, one patient had a prefascial abscess (2%), four hernia recurrences (9%), four chronic pain (9%), and two infections (5%). The major limitation of this study was that it was observational in nature, and the small sample size affects the validity and reliability of the study.
| DISCUSSION
There is a general agreement by many authors that repairing hernias by mesh, instead of simple suturing, has an improved the long-term complication and found the majority of the patients reported no complaints from the mesh; however, 5% required re-operation, and 3% (n = 46) developed a mesh infection. The sample size in the study was small, meaning the wider generalisability of the results is challenging. Whilst both these studies examined the long-term impacts of the prosthetic mesh, neither was able to provide clear conclusions regarding postoperative mesh complications. This is a problem for a patient undergoing surgery for a prosthetic mesh as they may be unaware of the long-term complications.
| Types of mesh
Gemici et al 21 tified that smoking was a major factor for re-operation for abscesses or necrosis of the wound. This finding was not a feature of the other studies examined in this review, which makes it difficult to make specific recommendations. However, the effect of smoking on wound failure rates is well recognised. 26 Wijeyekoon et al 23 found that the placement of the biological mesh did not have an effect on mortality and therefore concluded that biological mesh would be successful in different locations of the abdomen. Both studies showed the success of the prosthetic mesh; however, the small sample sizes limit the generalisability of the results. Similar to other studies, the long-term use of biological mesh and the risk of wound dehiscence is still unclear.
| Location of prosthetic mesh
Vascularised tissue is needed for herniorrhaphy reinforcement, and thus, the implant of a prosthetic mesh in nonvascularised location increases the risk of necrosis. 8 It has been shown that intraperitoneal or recto-rectus mesh placement decreases the overall postoperative complication rates and the chance of hernial reoccurrence. 30 Therefore, the placement of prosthetic mesh in an anatomical location needs careful consideration, particularly in high-risk patients, for example, patients with diabetes, obesity, and hypertension, to reduce the chance of tissue necrosis and increase the chance of wound repair. Briennon et al 16 found the Parietex composite mesh to be helpful in large ventral incisional hernias in terms of its low complication rate. They concluded that the prosthetic mesh was both safe and durable; however, careful consideration of placement was necessary for these patients. The study provides support for the practicality of prosthetic mesh implants and the success in patients with complex abdominal hernias, indicating that it can be used in severe cases; however, careful consideration needs to be given to the patient selection for the procedure. Sommer and Friis-Andersen 14 found that the polyvinylidene fluoride prosthetic mesh has a relatively long-term benefit in ventral abdominal hernias and thus can be used for this purpose.
| Potential reason of mesh rejection
A common factor across the studies in this review was a female preponderance for mesh failure. 21, 26, 28 Existing epidemiological data for England indicate that more women have bariatric surgery, 22 which could explain the higher ratio of females requiring more elective hernia repair. It would be interesting to examine this aspect in subsequent studies to determine if female gender presents a specific risk factor. Existing evidence indicates that obesity, diabetes, and hypertension increase the risk of postoperative complications after abdominal hernia wall repair. 31 Obesity is a factor that needs to be considered in abdominal wall hernia repair as severe obesity (defined as BMI >40) is a factor that predisposes to the development of abdominal wall herniation. 32 The increased abdominal pressure within these patients, along with poor wound healing, needs to be considered for the poor results of the prosthetic mesh. This may correlate with the small percentage of patients in a number of studies [14] [15] [16] [17] 22, 25, 28 for which the prosthetic mesh did not work. Overall, the clinical significance of the evidence examined for this review suggests that criteria for patient selection is key in determining when it may be appropriate to use prosthetic mesh implants. This review has also highlighted that more research on the use of biological mesh, which has a number of advantages including supporting revascularisation, being biodegradable, and enabling the mesh to become part of human tissue, 33 may be beneficial for patients who are not suitable for a prosthetic mesh.
| CONCLUSION
It appears that prosthetic mesh implants have gained global acceptance and have aided the repair of abdominal wall hernias in the majority of the patient on a worldwide scale; however, there is still a subset of patients suffering from postoperative complications. Whilst the underlying cause is still unclear, patients who are obese and/or have hypertension or diabetes have been identified as being at particular risk; therefore, careful patient selection is of vital importance to increase the success rate of prosthetic mesh implant surgery. Furthermore, the choice of mesh material and location of the mesh insertion are all important factors that may affect operation outcomes and therefore also needs to be considered. Overall, the long-term effect of prosthetic meshes is still not clear, with only a few studies examining the long-term outcomes. Therefore, further studies with a longer follow-up duration would be beneficial to provide a clearer indication of the risks.
